The Asian Breast Cancer Cooperative Group found a better prognosis for HER2-low BC compared with HER2 IHC score 0 in the early setting, although there was a modest absolute difference, mainly driven by HER2 IHC score 1+ tumors. Here, ERBB2 is linked to breast cancer.